glp 1 agonist delayed gastric emptying “Weighing In” on GLP-1 Receptor Agonists for People With HIV GLP-1 Receptor Agonists Explained for

A randomised controlled trial of treatment for idiopathic intracranial hypertension

GLP-1 receptor agonists and DPP4-inhibitor direct the T2DM therapies

Potential explanations include differences in the type of patients included, adherence to study treatment, sample size, duration of drug exposure, and GLP1 receptor activation with greater HbA1c reduction with longer-acting human GLP1-based analogs than with some short-acting exendin-4 analogs

By addressing potential financial barriers ahead of time, pharmacists can reduce treatment interruptions to prevent further GI complications

N Engl J Med 369:13171326 Meier JJ (2012) GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus